Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.20.473557Source: DataRank Database

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.561. It has been cited 41 times.

N/A

0.561DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (21)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.561

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (32)

Kelly E. Manning ORCID,Madison Ellis ORCID,Lilin Lai ORCID,Kathryn M. Moore ORCID,Stephanie L. Foster ORCID

Live enrichment

PubMed:34981056 OpenAlex:https://openalex.org/W4200479941

National Institutes of Health

Grant: 3P51OD011132-64S2

Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC

National Institutes of Health

Grant: 3U19AI057266-17S1

Vaccine Induced Immunity in the Young and Aged

National Institutes of Health

Grant: 5UL1TR002378-09

Georgia Clinical & Translational Science Alliance (Georgia CTSA)

National Institutes of Health

Grant: 3U54EB027690-02S1

Emergency COVID-19 supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technoloites (ACME POCT)

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/12/22/2021.12.20.473557.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.12.20.473557

repositoryhttps://doi.org/10.1101/2021.12.20.473557

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34981056

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing0303 health sciences03 medical and health sciences

Keywords

Neutralizing antibodyNeutralizationVirologyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Messenger RNASpike ProteinCoronavirus disease 2019 (COVID-19)ChemistryBiologyMedicineVirusGeneImmunologyGeneticsInfectious disease (medical specialty)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

FAIR Checklist

DataRank Breakdown

Authors (32)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)